Grantham, Mayo, Van Otterloo & Co (GMO)’s Endurance Specialty Holdings Ltd ENH Stock Holding History

Grantham, Mayo, Van Otterloo & Co (GMO)’s Portfolio ENH Stock Details ENH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-211,735	Closed	-$19.6M	–	673
2016 Q4	$19.6M	Buy	+211,735	New	+$19.4M	0.11%	147
2016 Q3	–	Sell	-13,135	Closed	-$882K	–	622
2016 Q2	$882K	Sell	13,135 -137,065	-91%	-$8.98M	﹤0.01%	428
2016 Q1	$9.81M	Sell	150,200 -750	-0.5%	-$46.9K	0.04%	239
2015 Q4	$9.66M	Sell	150,950 -3,000	-2%	-$193K	0.03%	202
2015 Q3	$9.4M	Buy	+153,950	New	+$10M	0.03%	195

Other funds holding ENH

FPF

FNY Partners Fund New York $185M AUM 32.57% 1-Year Est. Return

Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return

Grantham, Mayo, Van Otterloo & Co (GMO)'s ENH Position: Q1 2017 in Review

Grantham, Mayo, Van Otterloo & Co (GMO) sold out of Endurance Specialty Holdings Ltd (ENH) in Q1 2017, closing a stake of 211,735 shares — an estimated $19.6M sold.

Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in ENH in Q3 2015 and held it in 5 quarters. The position peaked at $19.6M in Q4 2016. 3 funds tracked by Wall St. Rank hold ENH as of Q1 2017.

Grantham, Mayo, Van Otterloo & Co (GMO) reported no remaining Endurance Specialty Holdings Ltd position as of Q1 2017 after selling out during the quarter.
Grantham, Mayo, Van Otterloo & Co (GMO) sold 211,735 Endurance Specialty Holdings Ltd shares in Q1 2017, an estimated $19.6M.
Grantham, Mayo, Van Otterloo & Co (GMO) first reported a position in Endurance Specialty Holdings Ltd in Q3 2015 and held it in 5 quarters.
Grantham, Mayo, Van Otterloo & Co (GMO)'s Endurance Specialty Holdings Ltd position peaked at $19.6M in Q4 2016.
3 funds tracked by Wall St. Rank held Endurance Specialty Holdings Ltd as of Q1 2017.

Based on Grantham, Mayo, Van Otterloo & Co (GMO)'s 13F filing for Q1 2017, filed 15 May 2017.